Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-16.50%
Monthly Change
-9.47%
6 month change
-16.50%
Year Change
-20.74%
Previous Close
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
Volume
15
Markets
US Stock Market
Healthcare
SEER
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
14.13 M
11.46 M
11.42 M
14.66 M
7.57 M
45.1 M
Cash from investing activities
26.44 M
15.85 M
24.61 M
7.36 M
16.6 M
64.42 M
Cash from financing activities
6.64 M
1.26 M
1.5 M
7.22 M
1.99 M
11.97 M
Free cash flow
11.94 M
11.99 M
10.76 M
14.09 M
7.28 M
44.13 M
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
News
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer apresenta crescimento de 67% na base instalada, mas receita decepciona
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Lucro da Seer superou projeções por $0,02; receita menor do que estimativas
Seer earnings beat by $0.02, revenue fell short of estimates
Seer apresentará tecnologia de proteômica em conferência nos EUA
Seer to showcase proteomics technology at US HUPO conference
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
Seer no Fórum CG MedTech: inovações em proteômica lideram o caminho
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way